by Lance Smith | Mar 10, 2020 | Study Scavenger Clinical Trial Recruitment Platform
BOSTON–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today presented longer-term results from the DISCOVER trial of Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets, F/TAF) for pre-exposure prophylaxis (PrEP), demonstrating...
by Lance Smith | Mar 10, 2020 | Study Scavenger Clinical Trial Recruitment Platform
WARREN, N.J., March 10, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced the successful completion of its End-of-Phase 2 Meetings with the U.S. Food and Drug...
by Lance Smith | Mar 10, 2020 | Study Scavenger Clinical Trial Recruitment Platform
On track to report topline data mid-2020 BOSTON, March 10, 2020 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced achievement of full patient...
by Lance Smith | Mar 10, 2020 | Study Scavenger Clinical Trial Recruitment Platform
CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today...
by Lance Smith | Mar 10, 2020 | Study Scavenger Clinical Trial Recruitment Platform
Anti-CD39 monoclonal antibody, IPH5201, advances to first-in-human clinical trial; first molecule from Innate/AstraZeneca expanded collaboration progressing to the clinic MARSEILLE, France, March 10, 2020 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH...
Email
Text